ABSTRACT
OBJECTIVES: To determine the proportion of abortions provided to patients from Texas in New Mexico before and after the 2013 enactment of Texas House Bill 2 (HB2), an omnibus bill of abortion restrictions, and to compare the gestational ages at which Texans presented for abortion in New Mexico before and after HB2. STUDY DESIGN: We conducted a chart review of Texas and New Mexico patients obtaining an abortion in New Mexico abortion clinics before HB 2 was signed and implemented (time period 1: January 1, 2012 to December 31, 2012) and after HB 2 went into effect (time period 2: May 1, 2014 to April 30, 2015). We used random sampling of corresponding 7-day periods (by week number during the one-year sample) to obtain data until we reached the desired sample of at least 300 patients. We compared proportions of individuals from Texas obtaining abortions and the gestational age at which they presented in the two time periods. RESULTS: We abstracted data from 350 and 300 Texas and New Mexico patients, respectively. The proportion of procedures provided to women from Texas increased from 10 (3%) pre-HB2 to 43 (14%) post-HB2 (p < 0.0001). The proportion of procedures in Texas patients at 13 to ≤24 weeks increased from 1 of 29 (3%) pre-HB2 to 10 of 38 (26%) post-HB2 (p = 0.012). CONCLUSION: The proportion of Texans scheduling abortions in New Mexico within the first 24 weeks of gestation increased after passage of HB2. Restrictive legislation may force more people to travel across state lines to obtain abortion care. IMPLICATIONS: Patients residing in Texas and seeking abortion care in Texas experienced barriers to abortion care, likely related to restrictions imposed by HB2.
Subject(s)
Abortion, Induced , Abortion, Legal , Ambulatory Care Facilities , Female , Humans , New Mexico , Pregnancy , Texas , TravelABSTRACT
PURPOSE OF REVIEW: This review examines evidence relevant to the effect of hormonal contraception on breastfeeding; and compares global and US recommendations for contraceptive initiation and use. Breastfeeding and use of postpartum contraception have high public health priority, making research in this area critical for optimizing guidance. RECENT FINDINGS: High quality evidence remains limited with only a small number of well-conducted randomized controlled trials of hormonal methods and breastfeeding/neonatal growth outcomes. More evidence supports early initiation of progestin-only methods. Evidence on early initiation of combination hormonal methods is sparse. SUMMARY: The WHO Medical Eligibility Criteria (MEC) differs from that of the US MEC. Generally, the WHO MEC is more restrictive, reflecting the potential greater impact on maternal child health if there is a negative impact from hormonal contraception on breastfeeding. Only well conducted clinical trials will further elucidate such an impact. VIDEO ABSTRACT: http://links.lww.com/COG/A15.
Subject(s)
Contraceptives, Oral, Hormonal/therapeutic use , Family Planning Services , Lactation/physiology , Postpartum Period/physiology , Adult , Breast Feeding , Cross-Cultural Comparison , Family Planning Services/education , Female , Guidelines as Topic , Humans , Infant, Newborn , Lactation/drug effects , Postpartum Period/drug effects , PregnancyABSTRACT
Actinomyces israelii is a gram-positive, filamentous anaerobic bacteria colonizing the oral and gastrointestinal tracts. Retroperitoneal actinomycotic abscess is uncommon and its rare presentation as a hemorrhagic mass may be confused with malignancy. We present a case of this unusual infection complicating pregnancy. Increased awareness of actinomycotic abscess in the differential diagnosis of renal mass concerning for malignancy is critical to early recognition and treatment of this rare infection and most importantly, avoidance of unnecessary surgical intervention.
